Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Bonaventure

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Frontiers in Neuroscience|June 7, 2014
Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortexLeah Aluisio, Ian Fraser, Tamara Berdyyeva, et al.
European Journal of Pharmacology|May 3, 2005
Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dogPascal Bonaventure, Diane Nepomuceno, Kirsten Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2004
Pharmacological characterization of relaxin-3/INSL7 receptors GPCR135 and GPCR142 from different mammalian speciesJingcai Chen, Chester Kuei, Steven W Sutton, et al.
European Journal of Pharmacology|June 18, 2011
Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonistsDa-Thao Tran, Pascal Bonaventure, Michael Hack, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2003
Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptorPascal Bonaventure, Diane Nepomuceno, Curt Mazur, et al.
Frontiers in Behavioral Neuroscience|May 24, 2017
Selective Inhibition of Orexin-2 Receptors Prevents Stress-Induced ACTH Release in MiceSujin Yun, Michelle Wennerholm, Jonathan E Shelton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 12, 2014
PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigsMichael Winterdahl, Hélène Audrain, Anne M Landau, et al.
Frontiers in Neuroscience|March 19, 2019
<i>In vivo</i> Calcium Imaging Reveals That Cortisol Treatment Reduces the Number of Place Cells in Thy1-GCaMP6f Transgenic MiceTim Indersmitten, Michael J Schachter, Stephanie Young, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 2007
Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodentsPascal Bonaventure, Lisa Kelly, Leah Aluisio, et al.
Depression and Anxiety|September 3, 2015
OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSESPhilip L Johnson, Lauren M Federici, Stephanie D Fitz, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Frontiers in Neuroscience|June 7, 2014
Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortexLeah Aluisio, Ian Fraser, Tamara Berdyyeva, et al.
European Journal of Pharmacology|May 3, 2005
Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dogPascal Bonaventure, Diane Nepomuceno, Kirsten Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2004
Pharmacological characterization of relaxin-3/INSL7 receptors GPCR135 and GPCR142 from different mammalian speciesJingcai Chen, Chester Kuei, Steven W Sutton, et al.
European Journal of Pharmacology|June 18, 2011
Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonistsDa-Thao Tran, Pascal Bonaventure, Michael Hack, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2003
Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptorPascal Bonaventure, Diane Nepomuceno, Curt Mazur, et al.
Frontiers in Behavioral Neuroscience|May 24, 2017
Selective Inhibition of Orexin-2 Receptors Prevents Stress-Induced ACTH Release in MiceSujin Yun, Michelle Wennerholm, Jonathan E Shelton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 12, 2014
PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigsMichael Winterdahl, Hélène Audrain, Anne M Landau, et al.
Frontiers in Neuroscience|March 19, 2019
<i>In vivo</i> Calcium Imaging Reveals That Cortisol Treatment Reduces the Number of Place Cells in Thy1-GCaMP6f Transgenic MiceTim Indersmitten, Michael J Schachter, Stephanie Young, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 2007
Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodentsPascal Bonaventure, Lisa Kelly, Leah Aluisio, et al.
Depression and Anxiety|September 3, 2015
OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSESPhilip L Johnson, Lauren M Federici, Stephanie D Fitz, et al.
Pageof 10